The Cancer Drug Interactions website was set up in 2017 and is a joint venture between Radboud University Medical Centre in Nijmegen, Netherlands and the University of Liverpool, UK.
Dr Nielka van Erp
Dr Nienke Lankheet
Nienke is a Hospital Pharmacist, specialist in oncology patient care and Clinical Pharmacologist in training at Radboud University Medical Centre in Nijmegen. She obtained her PhD from the Netherlands Cancer Institute in Amsterdam for a research project into the clinical pharmacology of targeted agents in oncology. She is particularly interested in the pharmacology of oncolytics and therapeutic drug monitoring.
Kaylee graduated from the University of Utrecht as a pharmacist and was first involved in this website during her internship at the hospital pharmacy of the Radboudumc. Since September 2017, Kaylee has been working full time on this project researching the drug interactions and preparing the summaries for the website.
Stefanie joined the team after finishing her training as a Hospital Pharmacist in May 2018. She is a PhD candidate and a Hospital Pharmacist Fellow specialising in oncology patient care at the Radboud University Medical Center. She is particularly interested in strategies to enhance efficacy and reduce toxicity of anti-cancer agents.
Dr Frank Jansman
Frank is a Hospital Pharmacist and Clinical Pharmacologist at the Deventer Teaching Hospital and at the University Groningen. He is particularly interested in pharmacotherapy and pharmaceutical care of cancer patients and in clinical toxicology. Frank is chairman of the Dutch Working Group for Interactions Anticancer Drugs (Dutch Association of Hospital Pharmacists, Dutch Society for Medical Oncology, Haemato Oncology Foundation for Adults in the Netherlands, Dutch Society of Clinical Pharmacology and Biopharmacy) and chairman of the Dutch Working Group for Pharmacotherapy and Drug Information (Royal Dutch Pharmacists Association).
Prof David Burger
David is a Professor of Clinical Pharmacy, Radboud University Nijmegen and is (co-) author of more than 350 publications in this field. The topics of his interest are drug-drug interactions, paediatric pharmacology, therapeutic drug monitoring, and operational research in resource-limited countries. David is member of the Editorial Board of www.hiv-druginteractions.org and www.hep-druginteractions.org and member of the Organizing Committee of the annual International Workshop on Clinical Pharmacology of Antiviral Therapy.
Prof Saye Khoo
Saye is a Professor of Clinical Pharmacology at the University of Liverpool and Honorary Consultant Physician, Royal Liverpool and Broadgreen University Hospitals NHS Trust. His primary research interests centre on the pharmacology of HIV treatment failure, including investigation of drug interactions, the role of therapeutic drug monitoring, population pharmacokinetic modelling, molecular characterisation of drug metabolism and disposition pathways and the role of host genetic variability in influencing drug exposure and response.
Jasmine obtained a BSc (Hons) degree in Pharmacology from the University of Liverpool in 2016 and, after completing a Master degree by research, she joined the website team in August 2017 working mainly on the cancer drug interactions website. In March 2020, Jasmine took up the post of Development Manager for all the websites (HIV, HEP, COVID and Cancer) and is responsible for developing partnerships and projects which support our mission and ethos.